LSE - Delayed Quote GBp
OptiBiotix Health Plc (OPTI.L)
As of 9:21 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
644.00
644.00
457.00
2,213.00
1,523.25
Cost of Revenue
324.00
324.00
213.00
1,090.00
643.43
Gross Profit
320.00
320.00
244.00
1,123.00
879.82
Operating Expense
2,015.00
2,015.00
10,763.00
2,488.00
1,991.21
Operating Income
-1,695.00
-1,695.00
-10,519.00
-1,365.00
-1,111.39
Net Non Operating Interest Income Expense
1.00
1.00
--
-48.00
-44.86
Pretax Income
-2,043.00
-2,043.00
2,441.00
6,177.00
5,710.23
Tax Provision
-4.00
-4.00
-146.00
-84.00
-91.64
Net Income Common Stockholders
-2,039.00
-2,039.00
2,587.00
6,261.00
5,801.87
Diluted NI Available to Com Stockholders
-2,039.00
-2,039.00
2,587.00
6,261.00
5,801.87
Basic EPS
-0.15
-0.02
0.03
0.07
0.07
Diluted EPS
-0.15
-0.02
0.03
0.07
0.06
Basic Average Shares
88,396.13
90,190.66
88,279.95
87,574.15
87,207.70
Diluted Average Shares
96,920.81
98,273.57
93,213.18
95,536.40
95,569.95
Total Operating Income as Reported
-1,695.00
-1,695.00
-2,489.00
-1,365.00
-1,111.39
Total Expenses
2,339.00
2,339.00
10,976.00
3,578.00
2,634.64
Net Income from Continuing & Discontinued Operation
-2,039.00
-2,039.00
2,587.00
6,261.00
5,801.87
Normalized Income
-2,013.05
-2,013.05
-7,977.83
113.10
-5.78
Interest Income
1.00
1.00
--
--
0.10
Interest Expense
--
--
--
48.00
44.95
Net Interest Income
1.00
1.00
--
-48.00
-44.86
EBIT
-2,043.00
-2,043.00
2,441.00
6,225.00
5,755.19
EBITDA
-1,838.00
-1,838.00
2,665.00
6,513.00
6,003.08
Reconciled Cost of Revenue
324.00
324.00
213.00
1,090.00
643.43
Reconciled Depreciation
205.00
205.00
224.00
288.00
247.90
Net Income from Continuing Operation Net Minority Interest
-2,039.00
-2,039.00
2,587.00
6,261.00
5,801.87
Total Unusual Items Excluding Goodwill
-26.00
-26.00
13,043.00
7,590.00
7,169.93
Total Unusual Items
-26.00
-26.00
13,043.00
7,590.00
7,169.93
Normalized EBITDA
-1,812.00
-1,812.00
-10,378.00
-1,077.00
-1,166.85
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-0.05
-0.05
2,478.17
1,442.10
1,362.29
12/31/2020 - 9/9/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBX.AQ ProBiotix Health Plc
4.4549
0.00%
SBTX.L SkinBioTherapeutics plc
14.27
-4.90%
AVCTF Avacta Group Plc
0.8404
0.00%
TCF.L Theracryf Plc
0.6400
+2.40%
IMM.L ImmuPharma plc
1.9462
+0.58%
TRX.L Tissue Regenix Group plc
53.50
-0.93%
OBD.L Oxford BioDynamics Plc
1.1339
+1.70%
FNCH Finch Therapeutics Group, Inc.
12.05
+2.56%
SNG.L Synairgen plc
5.40
+12.73%
AVCT.L Avacta Group Plc
56.00
-7.44%